-
Bank of America Raises PO On Intuitive Surgical To $385
Wednesday, July 20, 2011 - 6:17am | 28Bank of America has raised the price objective on Intuitive Surgical (NASDAQ: ISRG) from $365 to $385 and maintains its Neutral rating.
-
Goldman Upgrades Intuitive Surgical To Neutral, Raises PT TO $370
Wednesday, July 20, 2011 - 6:13am | 35Goldman Sachs has upgraded Intuitive Surgical (NASDAQ: ISRG) from Sell to Neutral (removing the company from America's Sell List) and has raised the price target from $282 to $370.
-
Earnings Scheduled For July 20
Wednesday, July 20, 2011 - 2:59am | 502Altria Group Inc (NYSE: MO) is expected to report its Q2 EPS at $0.53 on revenue of $4.43 billion. QUALCOMM Incorporated (NASDAQ: QCOM) is projected to report its Q3 EPS at $0.71 on revenue of $3.59 billion. eBay Inc (NASDAQ: EBAY)is projected to report its Q2 EPS at $0.46 on revenue of $2.61...
-
Stocks to Watch for Wednesday 7/20/2011: Fresh 52 Week Highs and Lows
Wednesday, July 20, 2011 - 1:51am | 3102Stocks trading at or near 52-week highs and lows provide excellent trading opportunities, as volatility tends to increase at such levels. The following stocks hit new 52-week highs in Tuesday's trading session (listed from highest total volume to lowest): 1) Apple (NASDAQ: AAPL): Shares of Apple...
-
4 Stocks for Your Watchlist
Tuesday, July 19, 2011 - 5:36pm | 2588( click to enlarge ) Cirrus Logic, Inc. (NASDAQ:CRUS) has had a hard time with resistance here, but may be ready to move higher. The level which the stock may have trouble moving above, is today at $17.20. It would need to break above that level to run to $19. The technical chart shows the...
-
Stryker Fades on the Back of Its Q2 Earnings Results
Tuesday, July 19, 2011 - 5:14pm | 179Shares of Stryker (NYSE: SYK) are bid lower in the after-hours following the release of the company's Q2 earnings results. Currently, shares are bid $58.50, at $58.54; they closed the regular session higher by 1.54%, at $59.16. Stryker said that Q2 Adjusted EPS came in at $0.90 on revenues of $2....
-
Options Brief: Thoratec
Tuesday, July 19, 2011 - 12:50pm | 75Shares of Thoratec (NASDAQ: THOR) are higher on the session by 3.91%, trading at $36.39. Overall put volume is now running at 2.05x the daily average, with 53% of all puts traded being purchases on the offer. 4,688 contracts have traded on the session so far. Thoratec Corporation is a...
-
Earnings Preview: Stryker EPS, Revenue Expected to Rise from Previous Quarter
Tuesday, July 19, 2011 - 12:39pm | 567Stryker (NYSE: SYK) earnings are right around the corner! Don't be caught off-guard: The company unveils its next round of earnings this Tuesday, July 19, 2011. Wondering what to expect from this Tuesday's announcement? Don't worry. Here's your essential guide to Stryker's second quarter earnings...
-
Tuesday's Put/Call Ratio Leaders
Tuesday, July 19, 2011 - 12:13pm | 77Here are today's Put/Call Ratio leaders… 1. Molex Inc. (NASDAQ: MOLX) 2,510 puts, 75 calls 2. Thoratec Corp. (NASDAQ: THOR) 6,194 puts, 399 calls 3. Raytheon Co. (NYSE: RTN) 5,722 puts, 578 calls 4. Encana Corp. (NYSE: ECA) 2,787 puts, 307 calls 5. Cerner Corp. (NASDAQ: CERN) 2,652 puts, 294 calls...
-
Options Brief: Edwards Lifesciences
Tuesday, July 19, 2011 - 10:15am | 68Shares of Edwards Lifesciences (NYSE: EW) are higher on the session by 0.04%, trading at $89.72. Overall call volume is now running at 2.67x the daily average, with 74% of all calls traded being purchases on the offer. 1,235 contracts have traded on the session so far. Edwards Lifesciences...
-
Hearing Negative Twitter Chatter on DexCom
Tuesday, July 19, 2011 - 9:49am | 30@markflowchatter reports that there is a reputable negative report out on DexCom (NASDAQ: DXCM).
-
Credit Suisse Outperform On Thoratec
Tuesday, July 19, 2011 - 9:33am | 196Credit Suisse is out with a research report on Thoratec Corp (NASDAQ: THOR) and it has an Outperform rating and a $43 price target on shares. In a note to clients, Credit Suisse writes, "We are initiating coverage on Thoratec Corporation with an Outperform rating and PT of $43. THOR is the leading...
-
Credit Suisse Neutral On Edwards Lifesciences
Tuesday, July 19, 2011 - 9:26am | 104Credit Suisse is out with a research report on Edwards Lifesciences Corp. (NYSE: EW) and it has a Neutral rating and a $99 price target on shares. In a note to clients, Credit Suisse writes, "Initiating at Neutral with a $99 price target: EW is a worldwide leader in the surgical and transcatheter...
-
UPDATE: Bank of America Initiates Coverage on Abaxis
Tuesday, July 19, 2011 - 9:22am | 132Bank of America has published a report on Abaxis (NASDAQ: ABAX) initiating coverage of the company. In the report, Bank of America wrote, "We initiate coverage of Abaxis (ABAX) with a Neutral rating and a $30 price objective. ABAX is a leading manufacturer of point-of-care diagnostic equipment,...
-
UPDATE: Bank of America Initiates Coverage on IDEXX Laboratories
Tuesday, July 19, 2011 - 9:15am | 125Bank of America has published a report on on IDEXX Laboratories (NASDAQ: IDXX) initiating coverage of the laboratory. In the report, Bank of America wrote, "We initiate coverage of IDEXX Laboratories (IDXX) with a Buy rating and a $90 price objective. IDXX is the leading provider of diagnostic...